MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » Cardiac Dimensions taps ex-AccessClosure chief Casciaro for CEO | Personnel Moves

Cardiac Dimensions taps ex-AccessClosure chief Casciaro for CEO | Personnel Moves

By

MassDevice.com Personnel MovesCardiac Dimensions said this week that it tapped the former chief of AccessClosure, Gregory Casciaro, to be its new president & CEO.

Casciaro led AccessClosure until its May 2014 acquisition by Cardinal Health (NYSE:CAH) for $320 million. His résumé includes stints as the chief executive at drug-eluting stent maker Xtent, Orquest (acquired JNJ’s DePuy Acromed in 2003) and General Surgical Innovations (acquired by U.S. Surgical for $100 million in 1999).

Cardiac Dimensions is developing the Carillon mitral valve, which is designed to treat functional mitral regurgitation. In March, the Kirkland, Wash.-based company raised a $15 million round. Carillon won CE Mark approval in the European Union in 2011.

“With more than 33 years of medical device experience and a proven track record of success leading both private and public companies, Greg will be instrumental in guiding the future strategic direction of Cardiac Dimensions,” said Jan Garfinkle, member of Cardiac Dimensions’ Board of Directors. “Based on his extensive knowledge of the interventional cardiology space, we believe he is the ideal choice to take Cardiac Dimensions to the next level.”

“Cardiac Dimensions has an innovative platform that is designed to address the unmet needs of heart failure patients and the related condition of FMR,” Casciaro added. “The clinical data available for this therapy have demonstrated that it benefits patients significantly and, we believe, holds incredible promise for the future. I am excited to lead this talented team forward as we increase access to the therapy through continued global commercialization and expanded clinical work.”

 Ex-Sen. Harkin joins Masimo’s board
Masimo (NSDQ:MASI)
said it added former Sen. Tom Harkin to its board of directors. Harkin, who retired in January, served 5 terms in the Senate.
Read more

 Grifols plans family succession
Grifols (NSDQ:GRFS) chairman & CEO Víctor Grifols is stepping down, to be replaced by his brother, Raimon Grifols, and son Víctor Grifols, effective January 2017.
Read more

 Femasys names Creech as CFO
Femasys said it named Todd Creech, the ex-finance chief at ZS Pharma, to be its new CFO.
Read more

 Cellnovo’s new CTO is Sorin vet Masoud
Cellnovo said it appointed former Sorin Group (BIT:SRN) R&D executive Javaid Masoud to be its new chief technology officer.
Read more

In case you missed it

RSS From Medical Design & Outsourcing

  • Missouri S&T researchers tout patented implants created with bioactive glasses and metals
    Researchers at the Missouri University of Science and Technology are touting devices made of bioactive glasses and metals that could replace certain types of implants. The researchers recently received a patent for their implant comprised of bioactive glasses and metals that dissolve at the end of their operational lifespan. They see the potential for replacing… […]
  • Edwards Lifesciences to spend $100M to promote racial equity
    Edwards Lifesciences today announced that it established a Social Impact Investment Fund to advance racial equity in healthcare. The $100 million fund is a portfolio of investments aimed at advancing racial equity through economic development in Black and underserved communities in the U.S. “Events in 2020 prompted reflection on how we could expand Edwards’ active… […]
  • How to choose the right rubber material and process for your medical parts
    Creating a medical component with a rubber material requires careful attention to various factors that will affect performance and manufacturability. Material choices and manufacturing options present many trade-offs. Don Bonitati, Minnesota Rubber & Plastics The long list of material properties impacting an elastomer component’s performance includes your prospective polymer’s end-use environment, chemical compatibility, hardness, compression… […]
  • Introducing ‘BYOP’ clinical trials
    BYOD — “bring your own device” — became a common term in tech circles a decade ago. Now with primary care doctors playing a growing role in clinical trials, the provider of decentralized clinical research software Curebase (San Francisco) aims to popularize the concept of “BYOP” — “bring your own physician.” That is, the company is… […]
  • Beacon MedTech Solutions names Michael McGee as president
    Beacon MedTech Solutions — formerly Built Rite-Reliance and LSR Engineering — recently announced that it has appointed medtech contract manufacturing veteran Michael McGee as its president. McGee has more than 25 years of senior leadership experience in the space. He was most recently GM of Nordson Medical’s precision medical components businesses. He was also previously… […]
  • Tegra Medical announces new director of sales and marketing in Europe
    Tegra Medical announced that it appointed Darren Vine as its director of sales and marketing in Europe. Franklin, Mass.-based Tegra said in a news release that Vine will report to CEO and head of SFS division medical Walter Kobler, with responsibilities including the building of the company’s presence through expansion into new markets around the… […]
  • 5 challenges Boston Scientific overcame to make single-use scopes work
    FDA wanted single-use scopes to reduce potentially deadly superbug infections. Here’s how Boston Scientific made it happen. Boston Scientific’s Exalt Model D Single-Use Duodenoscope received FDA clearance in December 2019. It was the first device of its kind to hit the medical market. Just five months earlier, the FDA urged device manufacturers to move away from re-usable duodenoscopes with… […]
  • Veranex acquires Experien Group
    Veranex announced today that it acquired Experien Group, a provider of regulatory, quality and clinical consulting services for medtech companies. Raleigh, N.C.-based Veranex, which was created as a combination of companies after Summit Partners acquired Ximedica, Quartesian and Boston Healthcare Associates in June, offers integrated product development strategies and services to medtech companies. According to… […]
  • How Olympus is using AI to find patients for its COPD device
    Olympus recently announced its SeleCT Connect program, which uses diagnostic imaging AI to automatically screen which people might benefit from its Spiration valve system. Spiration is an FDA-designated breakthrough device for treating chronic obstructive pulmonary disease (COPD) patients. SeleCT Connect — offered as part of Olympus’ SeleCT quantitative computer tomography (QCT) analysis service — is… […]
  • Catheter & Medical Design and VitalDyne Medical rebrand as VitalPath
    Catheter & Medical Design and VitalDyne Medical — makers of complex medical catheter systems — have rebranded under the name VitalPath. The move comes about five months after CMD’s March 2021 acquisition of VitalDyne. The Roseville, Minn.–based company also has a new website at vitalpath.com. VitalPath will exhibit at booth  No. 1714 at MD&M West,… […]
  • Dymax touts newest formulations for medtech wearables
    Dymax is using MD&M West in Anaheim, Calif. next week to tout its newest formulations for assembling medical device wearables. The Dymax materials are free from IBOA and TPO, are compatible with common and difficult substrates, and have passed ISO 10993-10 for sensitization and irritation, according to the Torrington, Conn.–based company. For manufacturers involved with… […]